These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 591876)
1. Effects of the teratogenic folic acid antagonist, 9-methyl pteroylglutamic acid, on hydroxyproline levels in fetal rat limbs. Schmidt RR; Chepenik KP; Paynton BV J Embryol Exp Morphol; 1977 Oct; 41():289-94. PubMed ID: 591876 [No Abstract] [Full Text] [Related]
2. Effects of the teratogenic folic acid antagonist, 9-methyl pteroylglutamic acid on uronic acid levels in fetal rat limbs. Paynton BV; Schmidt RR; Cotler JM Biol Neonate; 1978; 33(3-4):162-6. PubMed ID: 678597 [TBL] [Abstract][Full Text] [Related]
3. In vitro effects of the teratogen and folic acid antagonist, 9-methyl pteroylglutamic acid, on glycosaminoglycan accumulation in fetal rat limbs. Schmidt RR; Abbott K; Cotler JM Teratology; 1982 Aug; 26(1):53-7. PubMed ID: 7135258 [TBL] [Abstract][Full Text] [Related]
4. 9-methyl pteroylglutamic acid, a synthetic analogue of folic acid: its effects on hexosamine levels in fetal rat limbs and other fetal tissues. Schmidt RR; Abbott PK; Cotler JM Biol Neonate; 1982; 41(1-2):52-6. PubMed ID: 7199941 [TBL] [Abstract][Full Text] [Related]
5. Effects of transitory maternal pteroylglutamic acid (PGA) deficiency on respiratory control ratios, phosphorylative capacity, and cytochrome oxidase activities of mitochondria from rat embryos. Chepenik KP; Waite BM Teratology; 1972 Apr; 5(2):191-8. PubMed ID: 4336911 [No Abstract] [Full Text] [Related]
6. Effect of a synthetic folic acid analogue, 9-methyl-pteroylglutamic acid, on fetal chondrogenesis: ultrastructural observations. Schmidt RR; Slobodian SA; Chepenik KP; Cotler JM Biol Neonate; 1983; 43(5-6):281-6. PubMed ID: 6871296 [TBL] [Abstract][Full Text] [Related]
7. Effects of transitory maternal pteroylglutamic acid (PGA) deficiency on levels of adenosine phosphates in developing rat embryos. Chepenik KP; Johnson EM; Kaplan S Teratology; 1970 Aug; 3(3):229-35. PubMed ID: 5471177 [No Abstract] [Full Text] [Related]
8. Effects of a teratogen (9-methyl pteroylglutamic acid) on oxygen consumption by dispersed embryonic rat cells. Netzloff M; Johnson EM; Kaplan S Teratology; 1972 Feb; 5(1):19-22. PubMed ID: 5062590 [No Abstract] [Full Text] [Related]
9. Development of embryonic rat eyes in organ culture. II. An in vitro approach to teratogenic mechanisms. Armstrong RC; Elias JJ J Embryol Exp Morphol; 1968 May; 19(3):407-14. PubMed ID: 4970007 [No Abstract] [Full Text] [Related]
10. Experiments on the biological activities of various fractions of the folic acid antagonist "X-methyl" folic acid. Stokstad EL; Okinaka O; Kusano G Arch Biochem Biophys; 1986 Nov; 251(1):260-5. PubMed ID: 3789733 [TBL] [Abstract][Full Text] [Related]
11. Simultaneous prevention of blood abnormalities and hereditary congenital amputations in a brachydactylous rabbit stock. Petter C; Bourbon J; Maltier JP; Jost A Teratology; 1977 Apr; 15(2):149-57. PubMed ID: 301294 [TBL] [Abstract][Full Text] [Related]
12. The influence of folate antagonists on the metabolism of folic acid and its reduced derivatives in rat liver and kidney. Bühring U; Shin YS; Fölsch E Cancer Res; 1977 Jan; 37(1):299-304. PubMed ID: 830415 [TBL] [Abstract][Full Text] [Related]
13. Nonclassical 2,4-diamino-8-deazafolate analogues as inhibitors of dihydrofolate reductases from rat liver, Pneumocystis carinii, and Toxoplasma gondii. Gangjee A; Zhu Y; Queener SF; Francom P; Broom AD J Med Chem; 1996 Apr; 39(9):1836-45. PubMed ID: 8627607 [TBL] [Abstract][Full Text] [Related]
14. Organ culture of limb buds from riboflavin-deficient and normal rat embryos in normal and riboflavin-deficient media. Shepard TH; Bass GL Teratology; 1970 May; 3(2):163-7. PubMed ID: 5446882 [No Abstract] [Full Text] [Related]
15. Estimation of creatine phosphokinase and hydroxyproline in the developing limb: its use in evaluating the effect of teratogens on myogenesis and chondrogenesis. Kwasigroch TE; Neubert D Teratog Carcinog Mutagen; 1980; 1(2):181-91. PubMed ID: 6119810 [TBL] [Abstract][Full Text] [Related]
16. The effects of drugs on embryonic development. Netzloff ML Ann Clin Lab Sci; 1976; 6(4):332-41. PubMed ID: 962297 [TBL] [Abstract][Full Text] [Related]
17. Incorporation of a phospholipid precursor into the hemochorionic and yolk sac placentas associated rat embryos. Chepnik KP; Waite BM Teratology; 1975 Jun; 11(3):247-55. PubMed ID: 1154290 [TBL] [Abstract][Full Text] [Related]
18. Enzymic differentiation of rat yolk-sac placenta as affected by a teratogenic agent. Johnson EM; Spinuzzi R J Embryol Exp Morphol; 1966 Oct; 16(2):271-88. PubMed ID: 5971990 [No Abstract] [Full Text] [Related]
19. Functional activity of the reduced folate carrier in KB, MA104, and IGROV-I cells expressing folate-binding protein. Westerhof GR; Rijnboutt S; Schornagel JH; Pinedo HM; Peters GJ; Jansen G Cancer Res; 1995 Sep; 55(17):3795-802. PubMed ID: 7641196 [TBL] [Abstract][Full Text] [Related]
20. Folic acid and pantothenic acid protection against valproic acid-induced neural tube defects in CD-1 mice. Dawson JE; Raymond AM; Winn LM Toxicol Appl Pharmacol; 2006 Mar; 211(2):124-32. PubMed ID: 16112698 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]